FABP2 and COVID-19: As gut permeability and enterocyte cell death go hand in hand in conditions such as sepsis and intestinal ischaemia/reperfusion33, and as SARS-CoV-2 infection has been observed to kill gut epithelial cells8, we expected that plasma FABP2 would also increase in COVID-19 patients.